Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/15/2014 10/16/2014 10/17/2014 10/20/2014 10/21/2014 Date
12.67(c) 13.19(c) 12.7(c) 12.92(c) 13.01 Last
134 886 170 260 152 303 75 609 15 663 Volume
+1.52% +4.10% -3.71% +1.73% +0.70% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The... 
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 54,5 M
EBIT 2014 -3,74 M
Net income 2014 2,35 M
Debt 2014 -
Yield 2014 -
Sales 2015 82,5 M
EBIT 2015 6,70 M
Net income 2015 10,3 M
Debt 2015 -
Yield 2015 -
PER 2014 234,91
PER 2015 43,80
Capi. / Sales 2014 8,14x
Capi. / Sales 2015 5,37x
Capitalization 443 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
4d ago OSIRIS THERAPEUTICS : and Arthrex announce an exclusive partnership for the comm..
5d ago OSIRIS THERAPEUTICS : to present three studies on benefits of cryopreserved plac..
5d ago OSIRIS THERAPEUTICS : Schedules Third Quarter Results Release
10/13 OSIRIS THERAPEUTICS : Announces Third Quarter 2014 Financial Results Conference ..
10/03 OSIRIS THERAPEUTICS : to Present at the 2014 Stem Cell Meeting on the Mesa
09/25 OSIRIS THERAPEUTICS : to Present at the 2014 Stem Cell Meeting on the Mesa
09/24 OSIRIS THERAPEUTICS : Grafix® Featured in Plenary Session Oral Presentation at t..
09/18 OSIRIS THERAPEUTICS : Presents at Joint Annual Meeting of the Eastern and New En..
09/17 OSIRIS THERAPEUTICS : Grafix® Randomized Controlled Clinical Trial Recognized as..
09/16 OSIRIS THERAPEUTICS : Rolls Out Supplement in Wounds
09/15 OSIRIS THERAPEUTICS : Grafix® Featured in Plenary Session Oral Presentation at t..
09/11 OSIRIS THERAPEUTICS : Grafix® Randomized Controlled Clinical Trial Recognized as..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF